Volume 32, Issue 4 - Biotechnology
Advances in the CRISPR-Cas9 system and gene therapy
Author: Archana Nagarajan
Abstract
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas9 is a genome editing tool that helps scientists modify the DNA of living organisms selectively and precisely. The discovery of this system has led to changes in the approaches to gene therapy. In this article, I delve into the role of CRISPR-Cas9 in the development of treatment using gene therapy and the drawbacks of this system. Also, I discuss the role of medical writers in the dissemination of information and research on CRISPR-Cas9 and gene therapy.
Medical Writing. 2023;32(4):46–49. https://doi.org/10.56012/lzwz4471
Download the full article
Visit the EMWA website
Search
Articles
Links
Editoral Board
Editor-in-Chief
Co-Editors
Managing Editor
Victoria White
Deputy Managing Editor
Alicia Brooks Waltman
Associate Editors
Section Editors
AI/Automation
Biotechnology
Digital Communication
EMWA News
Freelancing
Gained in Translation
Getting Your Foot in the Door
Good Writing Practice
Pablo Izquierdo / Alison McIntosh
In the Bookstores
Publications
Medical Communications/Writing for Patients
Medical Devices
My First Medical Writing
News from the EMA
Pharmacovigilance
Regulatory Matters
Regulatory Public Disclosure
Louisa Ludwig-Begall / Sarah Kabani
The Crofter: Sustainable Communications
Veterinary Writing
Editors Emeritus
Layout Designer
Chris Monk